床旁诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

护理点诊断市场按产品、最终用户(医院/重症监护设置、门诊护理设置、研究实验室和其他最终用户)和地理位置进行细分。

护理点诊断市场快照

Point of care Diagnostics Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.8 %
Point of care Diagnostics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,床旁诊断市场的复合年增长率预计为 9.8%。导致市场增长的主要因素之一是发展中经济体慢性病和传染病的流行率上升。由于各种原因,如老年人口增加、久坐不动的生活方式、不健康的饮食习惯和环境因素,全球慢性疾病(如糖尿病、风湿病或癌症)的患病率正在增加。例如,慢性病每年在全球造成超过 3800 万人死亡。心血管疾病占慢性病死亡人数最多,即每年 1750 万人,其次是癌症(820 万人)、呼吸系统疾病(400 万人)和糖尿病(150 万人)。上述疾病占所有慢性疾病死亡的 82%。

在预测期内,诸如新型免疫测定技术的监管批准数量增加、技术进步以及家用 POC 设备使用量增加等因素预计将推动市场增长。

报告范围

即时检测诊断具有许多优点,它允许患者在许多地方进行诊断,例如在医生办公室、救护车、家中、现场或医院中。护理结果及时,为患者提供快速治疗。

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计血糖检测将在产品细分类型中占据主要收入份额

由于手持式血糖仪的成功,由于其在全球人口中的高采用率,血糖检测即时诊断在 2019 年占据了最大份额。定期监测血糖水平对糖尿病患者至关重要,这鼓励了该细分市场的糖尿病患者采用 POC。与手持式血糖仪相关的其他优点是便携性和易于操作性。预计全球糖尿病患病率的上升将推动未来该细分市场的增长。

Point of care Diagnostics Market Trends

北美在市场上占主导地位,预计在预测期内也会如此

目前,北美在即时诊断市场上占据主导地位,预计将在未来几年继续占据主导地位。在北美地区,美国占有最大的市场份额。这主要归因于该国老年人口基数的增长,以及诸如疾病流行率上升以及政府为发展医疗保健基础设施而采取的有利法规和举措等因素。

Point of care Diagnostics Market Growth

竞争格局

即时诊断市场竞争适度,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者主导市场。随着疾病流行率的上升和人口老龄化的增加,预计其他参与者也将进入市场。该市场的一些主要参与者包括雅培、西门子公司、Becton、狄金森公司、强生公司和 F. Hoffmann-La Roche Ltd 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies

      2. 4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques

      3. 4.2.3 Technological Advancements

      4. 4.2.4 Rising Usage of Home-based POC Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Product Recalls by Major Players Demotivate New Entrants

      2. 4.3.2 Stringent Regulatory Policies and Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Glucose Monitoring Kit

      2. 5.1.2 Cardio-metabolic Monitoring Kit

      3. 5.1.3 Pregnancy and Fertility Testing Kit

      4. 5.1.4 Infectious Disease Testing Kit

      5. 5.1.5 Cholesterol Test Strip

      6. 5.1.6 Hematology Testing Kit

      7. 5.1.7 Other Products

    2. 5.2 By End User

      1. 5.2.1 Hospital/Critical Care Setting

      2. 5.2.2 Ambulatory Care Setting

      3. 5.2.3 Research Laboratory

      4. 5.2.4 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Siemens AG

      3. 6.1.3 Beckman Coulter Inc.

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Instrumentation Laboratory

      6. 6.1.6 Johnson and Johnson

      7. 6.1.7 Nova Biomedical

      8. 6.1.8 Qiagen

      9. 6.1.9 F. Hoffmann-La Roche Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Point-of-care Diagnostics Market market is studied from 2018 - 2026.

The Point-of-care Diagnostics Market is growing at a CAGR of 9.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott, Siemens AG, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen are the major companies operating in Point-of-care Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!